Breathe Well Live Well
HCPLive |
Asthma Therapy Target Identified
HCPLive Researchers from the Medical College of Wisconsin believe this discovery is the first step in developing a novel type of asthma therapy which could be designed to prevent its onset in young children. In previous research, the investigators found a … |
View full post on asthma – Google News
Fox News |
Scientists find potential new therapy for hard-to-treat pediatric asthma patients
Fox News Between 40 and 70 percent of childhood asthma patients don't respond well to common treatment, but because doctors believe a variety of factors— from the environment to genetics— affect the condition, identifying those who are resistant before an … Genetic variance explains poor response to common asthma medications Public Release: 21-Apr-2015 Genetic variance explains poor response to … Genetic Variance Explains Poor Response to Asthma Medications |
View full post on asthma – Google News
Condition: Childhood Asthma
Interventions: Behavioral: ACT; Behavioral: An educational talk
Sponsors: The Hong Kong Polytechnic University; Hospital Authority, Hong Kong
Not yet recruiting – verified April 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Lung Disease News |
FDA Rejects GSK's Breo Ellipta Asthma Therapy Use in Adolescents; Adult Use …
Lung Disease News GSK Incruse Ellipta COPD The U.S. Food and Drug Administration (FDA) ruled against the use of GlaxoSmithKline's new drug combination Breo Ellipta in asthma patients between the ages of 12 and 17. However, the Pulmonary-Allergy Drugs Advisory … |
View full post on asthma – Google News
Conditions: Bronchiolitis; Pneumonia; Bronchial Asthma
Intervention:
Sponsor: McMaster University
Not yet recruiting – verified March 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Tiotropium improved asthma control as add-on therapy to ICS
Healio “Our findings show that in patients with moderate asthma who are receiving medium-dose inhaled corticosteroids, addition of once-daily tiotropium significantly improves lung function and asthma control compared with placebo, and has similar efficacy … |
View full post on asthma – Google News
Lung Disease News |
Gallopamil Proves to Be an Effective Therapy in Severe Asthma
Lung Disease News Asthma is a common chronic inflammatory lung disease characterized by airflow obstruction that causes wheezing (whistling sound when the person breathes), shortness of breath, chest tightness, and coughing. This respiratory disorder is thought to be … |
View full post on asthma – Google News
|
Aerospan improved pediatric asthma outcomes, regardless of prior therapy
Healio “The study findings indicate Aerospan is an effective treatment option for patients that require an inhaled steroid, such as those with mild to moderate asthma,” Karafilidis said. “This, coupled with our other data that suggest Aerospan did not … |
View full post on asthma – Google News
|
Boehringer Presents New Phase III Data for Asthma Therapy Tiotropium
Lung Disease News Boehringer Ingelheim Pharmaceutical company Boehringer Ingelheim recently presented encouraging data regarding its investigational drug tiotropium delivered through the company's Respimat inhaler, for the treatment of asthma. The data was presented … Tiotropium improves lung function in asthma, regardless of allergic status |
View full post on asthma – Google News
Times of Malta |
Gene discovery could improve asthma therapy
Futurity: Research News Scientists have discovered more than 30 genes that strongly affect an antibody involved in allergies and asthma. Some of the genes could provide targets for drugs to treat those conditions, according to the new study. Allergies affect as much as 30 … Genes involved in Allergies, Asthma identified Genes' 'key role' in asthma Genes involved in allergies, asthma discovered: Scientists |
View full post on asthma – Google News